Comunicazione Importante
Per l'intero 2020, tutte le attività - incluse quelle originariamente programmate in presenza - verranno erogate in forma digitale al fine di garantire ai docenti e discenti la massima sicurezza.
Ultime attività
Segnalazioni
Mercoledì 16 Settembre 2020
FEAM: Short position paper in response to the EU Pharmaceutical Strategy consultation
FEAM welcomes the opportunity to respond to the open consultation on the Pharmaceutical Strategy for Europe. The COVID-19 pandemic has illustrated the importance of strengthening the EU’s health research and biomedical R&D landscape. While biomedical innovation has now received an additional boost in the EU’s pandemic recovery strategy,[1] carrying the European health research enterprise forward will require addressing challenges across the life cycle of health technologies – from basic research to commercialization[2] and eventually to access for patients. As we have learned during the past few months, an important degree of flexibility to define and update priorities, and a sound regulatory system for approval of medicines, including a rapid and robust mechanism to approve drugs in emergency situations -for example in pandemics- will be essential to address future crises.[…]
Leggi la dichiarazione della FEAM (Federation of European Academies of Medicine) sulle nuove strategie farmaceutiche in Europa qui: FEAM Position Statement on the new Pharmaceutical Strategy for Europe
Lunedì 21 Settembre 2020
Cancer & Immunotherapy: greatest challenges and novel therapies inspiring European citizens
Evento organizzato dalla FEAM European Biomedical Policy Forum and Cancer Research UK.
Riconoscimenti
ISO 9001:2015
Qualità
Visita anche
©Accademia Nazionale di Medicina | Cod. fiscale e P. IVA: 04208241002 | Webmaster | Privacy Policy | Legge 124/2017
Realizzato da
Realizzato da